Find reports on global pharmaceutical companies. Piribo has indentified the top 50 global companies (by sales) and they have their own categories.
In A-Z order:
Abbott, Actavis, Alcon, Allergan, Amgen, Astellas, AstraZeneca, Barr Pharmaceuticals, Baxter, Bayer, Biogen Idec, Boehringer-Ingelheim, Bristol-Myers Squibb, Chugai, CSL, Daiichi Sankyo, Eisai, Eli Lilly, Forest, Genentech, Genzyme, Gilead Sciences,GlaxoSmithKline Johnson & Johnson, King Pharmaceuticals, Lundbeck, Menarini, Merck , Merck KGaA, Mitsubishi Tanabe, Mundipharma, Novartis, Novo Nordisk, Nycomed, Otsuka, P&G, Pfizer, Ratiopharm, Roche, Sanofi-Aventis, Schering-Plough, Servier, Shire, Solvay, Stada, Takeda,Teva UCB, Watson and Wyeth
Stay up-to-date with new products added to this category »
|
Title
|
Publication Date
|
Price
|
|
Shionogi: Pipeline, Products, Performance, Potential
|
January 2012 |
£595 |
|
Solvay: Pipeline, Products, Performance, Potential
|
January 2012 |
£595 |
Schering-Plough
Pipeline ,Products ,Performance ,Potential
|
January 2012 |
£595 |
|
Ono Pharmaceutical: Pipeline, Products, Performance, Potential
|
January 2012 |
£595 |
Pfizer
Pipeline - Products - Performance - Potential
|
January 2012 |
£595 |
|
IMS Company Profiles: Roche
|
January 2012 |
£640 |
|
Top 500 Chemists & Pharmacies (Global)
|
January 2012 |
£950 |
|
Top 550 Chemists & Pharmacies (European)
|
January 2012 |
£800 |
|
IMS Company Profiles: AstraZeneca
|
January 2012 |
£640 |
|
IMS Company Profiles:Sanofi
|
December 2011 |
£640 |
|
IMS Company Profiles:Forest
|
December 2011 |
£640 |
|
IMS Company Profiles:Takeda
|
December 2011 |
£640 |
|
IMS Company Profiles:Novartis
|
December 2011 |
£640 |
|
IMS Company Profiles:Hikma
|
November 2011 |
£640 |
|
IMS Company Profiles:Otsuka
|
November 2011 |
£640 |
|
IMS Company Profiles: Astra Zeneca
|
November 2011 |
£640 |
|
IMS Company Profiles:Biogen Ibec
|
November 2011 |
£640 |
|
IMS Company Profiles: Pfizer
|
October 2011 |
£640 |
|
Partnering Agreements with Abbott
|
September 2011 |
£630 |
|
Top 100 Global Chemists & Pharmacies Industry Analysis
|
August 2011 |
£820 |
Top 50 Pharmaceutical Companies Report - Global
Business Performance Analysis
|
August 2011 |
£820 |
Merck KGaA
Strategy, SWOT, and Corporate Finance Report
|
June 2011 |
£79 |
Bayer AG
Strategy, SWOT, and Corporate Finance Report
|
June 2011 |
£79 |
|
IMS Company Profiles:Boehringer Ingleheim
|
June 2011 |
£640 |
|
IMS Company Profiles:Johnson & Johnson
|
May 2011 |
£640 |
|
IMS Company Profiles: Daiichi Sankyo
|
March 2011 |
£640 |
|
Abbott Laboratories - SWOT Framework Analysis
|
January 2011 |
£63 |
|
Johnson and Johnson - SWOT Framework Analysis
|
January 2011 |
£63 |
|
Allergan - SWOT Framework Analysis
|
January 2011 |
£63 |
|
Pfizer - SWOT Framework Analysis
|
January 2011 |
£63 |
